Document is current

Article History

Received: 24 August 2023

Accepted: 29 August 2024

First Online: 14 September 2024

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Antonine University, Hadat-Baabda (CEUA) (reference number 279–2022, date of approval: February 16, 2022). The therapy center is located with ClimbAID in Tanaayel, Lebanon. Scientifically, Erlangen, Germany, is the primary coordinating center. Participation was voluntary, and participants were free to leave the study at any time without suffering any disadvantages. All participants were informed about the study by members of ClimbAID in a face-to-face meeting. A patient information sheet including all important information about participation (e.g., randomization, data protection, data storage) was given to every participant and was also available online. The opportunity to ask questions was granted at the trial sessions or by telephone and e-mail afterwards at any time. Informed consent was obtained from all participants and their legal guardians (if applicable) prior to their inclusion in the study.

: Not applicable.

: The authors declare no competing interests.